CHRISTINA BALDWIN N.P.
Prescription History 1982983011
Nurse Practitioner - Adult Health in New York, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for CHRISTINA BALDWIN N.P., an active Adult Health specialist practicing in New York, NY. Our medical registry currently tracks 28 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,375 documented patient claims. Among these therapy options, the most frequently utilized medication is Valacyclovir, which accounts for 184 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| ValacyclovirValacyclovir Hcl | 184 | $65.73 | ▲ More than typical |
About Valacyclovir: Valacyclovir is used to treat infections caused by certain types of viruses. Show more ▾ In children, it is used to treat cold sores around the mouth (caused by herpes simplex) and chickenpox (caused by varicella zoster). In adults, it is used to treat shingles (caused by herpes zoster) and cold sores around the mouth. Valacyclovir is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, this medication is used to reduce the number of future episodes. Valacyclovir is an antiviral drug. It stops the growth of certain viruses. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Valacyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. A prodrug of acyclovir that is used in the treatment of HERPES ZOSTER and HERPES SIMPLEX VIRUS INFECTION of the skin and mucous membranes, including GENITAL HERPES. In 2024, this provider wrote 184 Medicare prescriptions for Valacyclovir, about 7.6 times the volume of the typical New York prescriber of this medication (24.3). Medicare paid an average of $65.73 per fill, versus $29.38 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 431.6 30-Day Fills standardized to 30-day supplies 12,905 Days of Medication total across all patients in 2024 | |||
| VenclextaVenetoclax | 156 | $11,238.50 | ▲ More than typical |
About Venclexta: This medication is used to treat certain types of cancer (chronic lymphocytic leukemia-CLL, small lymphocytic lymphoma-SLL, acute myeloid leukemia-AML). Show more ▾ Venetoclax is a drug that works by helping to slow or stop the growth of cancer cells. A BCL-2 inhibitor with antineoplastic activity that is used in the treatment of CHRONIC LYMPHOCYTIC LEUKEMIA associated with chromosome 17p deletion. In 2024, this provider wrote 156 Medicare prescriptions for Venclexta, about 5.8 times the volume of the typical New York prescriber of this medication (27.1). Medicare paid an average of $11,238.50 per fill, versus $9,577.28 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 156 30-Day Fills standardized to 30-day supplies 4,665 Days of Medication total across all patients in 2024 | |||
| BrukinsaZanubrutinib | 146 | $13,703.64 | ▲ More than typical |
About Brukinsa: This medication is used to treat certain cancers (mantle cell lymphoma, marginal zone lymphoma, Waldenstrom's macroglobulinemia, chronic lymphocytic leukemia, small lymphocytic lymphoma, follicular lymphoma). Show more ▾ Zanubrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. A Bruton tyrosine kinase (BTK) inhibitor for treatment of Waldenstrom macroglobulinemia. In 2024, this provider wrote 146 Medicare prescriptions for Brukinsa, about 4.1 times the volume of the typical New York prescriber of this medication (35.6). Medicare paid an average of $13,703.64 per fill, versus $13,440.81 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 146 30-Day Fills standardized to 30-day supplies 4,380 Days of Medication total across all patients in 2024 | |||
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 137 | $7.86 | ▲ More than typical |
About Sulfamethoxazole-Trimethoprim: This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. Show more ▾ It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. In 2024, this provider wrote 137 Medicare prescriptions for Sulfamethoxazole-Trimethoprim, about 5.2 times the volume of the typical New York prescriber of this medication (26.4). Medicare paid an average of $7.86 per fill, versus $4.43 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 288.6 30-Day Fills standardized to 30-day supplies 8,472 Days of Medication total across all patients in 2024 | |||
| CalquenceAcalabrutinib Maleate | 117 | $15,881.00 | ▲ More than typical |
About Calquence: This medication is used to treat certain types of cancer (such as mantle cell lymphoma, small lymphocytic lymphoma - SLL, chronic lymphocytic leukemia - CLL). Show more ▾ Acalabrutinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. Inhibits Bruton’s tyrosine kinase; has antineoplastic activity. In 2024, this provider wrote 117 Medicare prescriptions for Calquence, about 4.2 times the volume of the typical New York prescriber of this medication (28.0). Medicare paid an average of $15,881.00 per fill, versus $14,010.64 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 117 30-Day Fills standardized to 30-day supplies 3,510 Days of Medication total across all patients in 2024 | |||
| Acyclovir | 113 | $23.49▼ below NY avg | ▲ More than typical |
About Acyclovir: Acyclovir is used to treat infections caused by certain types of viruses. Show more ▾ It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections. A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. In 2024, this provider wrote 113 Medicare prescriptions for Acyclovir, about 3.7 times the volume of the typical New York prescriber of this medication (30.3). Medicare paid an average of $23.49 per fill, versus $25.41 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 320.9 30-Day Fills standardized to 30-day supplies 9,603 Days of Medication total across all patients in 2024 | |||
| ImbruvicaIbrutinib | 65 | $17,232.70 | ▲ More than typical |
About Imbruvica: This medication is used to treat certain cancers (such as chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Show more ▾ Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system). A Btk protein inhibitor. In 2024, this provider wrote 65 Medicare prescriptions for Imbruvica, about 2.4 times the volume of the typical New York prescriber of this medication (27). Medicare paid an average of $17,232.70 per fill, versus $15,824.19 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 70.4 30-Day Fills standardized to 30-day supplies 2,008 Days of Medication total across all patients in 2024 | |||
| Allopurinol | 54 | $12.95 | ≈ Typical |
About Allopurinol: Allopurinol is used to treat gout and certain types of kidney stones. Show more ▾ It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy. These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells. Allopurinol works by reducing the amount of uric acid made by the body. Increased uric acid levels can cause gout and kidney problems. A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms. In 2024, this provider wrote 54 Medicare prescriptions for Allopurinol, about 1.2 times the volume of the typical New York prescriber of this medication (45.6). Medicare paid an average of $12.95 per fill, versus $10.29 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 154 30-Day Fills standardized to 30-day supplies 4,620 Days of Medication total across all patients in 2024 | |||
| Ondansetron OdtOndansetron | 34 | $12.29▼ below NY avg | ▲ More than typical |
About Ondansetron Odt: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. Ondansetron works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 34 Medicare prescriptions for Ondansetron Odt, about 1.5 times the volume of the typical New York prescriber of this medication (22.9). Medicare paid an average of $12.29 per fill, versus $14.03 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 34 30-Day Fills standardized to 30-day supplies 582 Days of Medication total across all patients in 2024 | |||
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 33 | $10.32 | ≈ Typical |
About Amoxicillin-Clavulanate Potass: Amoxicillin/clavulanic acid is a combination penicillin-type antibiotic used to treat a wide variety of bacterial infections. Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. In 2024, this provider wrote 33 Medicare prescriptions for Amoxicillin-Clavulanate Potass, about 1.2 times the volume of the typical New York prescriber of this medication (27.8). Medicare paid an average of $10.32 per fill, versus $8.73 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 33 30-Day Fills standardized to 30-day supplies 507 Days of Medication total across all patients in 2024 | |||
| Entecavir | 31 | $438.16 | ≈ Typical |
About Entecavir: See also Warning section. Show more ▾ Entecavir is used to treat long-term hepatitis B infection. Hepatitis B is an infection of the liver caused by the hepatitis B virus. Long-term infection can cause liver damage, rarely liver cancer, and liver failure. Entecavir helps to decrease the amount of hepatitis B virus in your body. It is unknown if this medication lowers your chance of getting liver cancer or liver damage. Entecavir is an antiviral that belongs to a class of drugs known as hepatitis B virus nucleoside reverse transcriptase inhibitors. Entecavir is not a cure for hepatitis B. It does not prevent the spread of the virus to others through sexual contact or blood/body fluid contamination (such as sharing used needles). In 2024, this provider wrote 31 Medicare prescriptions for Entecavir, about 1.2 times the volume of the typical New York prescriber of this medication (25.9). Medicare paid an average of $438.16 per fill, versus $197.27 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 71 30-Day Fills standardized to 30-day supplies 2,130 Days of Medication total across all patients in 2024 | |||
| JaypircaPirtobrutinib | 31 | $18,284.35▼ below NY avg | ≈ Typical |
About Jaypirca: This medication is used to treat certain types of cancer (such as mantle cell lymphoma-MCL, chronic lymphocytic leukemia-CLL, small lymphocytic lymphoma-SLL). Show more ▾ Pirtobrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. An orally available, selective, non-covalent Bruton's tyrosine kinase inhibitor with potential antineoplastic activity. In 2024, this provider wrote 31 Medicare prescriptions for Jaypirca, about 1.2 times the volume of the typical New York prescriber of this medication (26.1). Medicare paid an average of $18,284.35 per fill, versus $20,861.51 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 31 30-Day Fills standardized to 30-day supplies 930 Days of Medication total across all patients in 2024 | |||
| Prednisone | 25 | $9.11 | ▼ Less than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2024, this provider wrote 25 Medicare prescriptions for Prednisone, about half the volume of the typical New York prescriber of this medication (46.6). Medicare paid an average of $9.11 per fill, versus $4.12 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 33 30-Day Fills standardized to 30-day supplies 788 Days of Medication total across all patients in 2024 | |||
| Dapsone | 22 | $78.50▼ below NY avg | ▲ More than typical |
About Dapsone: This medication is used to treat a certain type of skin disorder (dermatitis herpetiformis). Show more ▾ It is also used with other drugs to treat Hansen's disease. Dapsone belongs to a class of drugs known as sulfones. It works by decreasing swelling (inflammation) and stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A sulfone active against a wide range of bacteria but mainly employed for its actions against MYCOBACTERIUM LEPRAE. Its mechanism of action is probably similar to that of the SULFONAMIDES which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with PYRIMETHAMINE in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8) In 2024, this provider wrote 22 Medicare prescriptions for Dapsone, about 1.3 times the volume of the typical New York prescriber of this medication (16.9). Medicare paid an average of $78.50 per fill, versus $82.77 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 62 30-Day Fills standardized to 30-day supplies 1,860 Days of Medication total across all patients in 2024 | |||
| Omeprazole | 21 | $21.84 | ▼ Less than typical |
About Omeprazole: Omeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). Show more ▾ It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Omeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). If you are self-treating with this medication, over-the-counter omeprazole products are used to treat frequent heartburn (occurring 2 or more days a week). Since it may take 1 to 4 days to have full effect, these products do not relieve heartburn right away. For over-the-counter products, carefully read the package instructions to make sure the product is right for you. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar brand names may contain different ingredients meant for different purposes. Taking the wrong product could harm you. A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. In 2024, this provider wrote 21 Medicare prescriptions for Omeprazole, about a quarter of the volume of the typical New York prescriber of this medication (99.1). Medicare paid an average of $21.84 per fill, versus $11.48 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 55 30-Day Fills standardized to 30-day supplies 1,618 Days of Medication total across all patients in 2024 | |||
| Pantoprazole Sodium | 20 | $17.36 | ▼ Less than typical |
About Pantoprazole Sodium: Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). Show more ▾ It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER. In 2024, this provider wrote 20 Medicare prescriptions for Pantoprazole Sodium, about a third of the volume of the typical New York prescriber of this medication (70). Medicare paid an average of $17.36 per fill, versus $11.79 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 54 30-Day Fills standardized to 30-day supplies 1,620 Days of Medication total across all patients in 2024 | |||
| Atovaquone | 20 | $703.17 | ≈ Typical |
About Atovaquone: Atovaquone is used to prevent or treat a serious lung infection called Pneumocystis pneumonia (PCP). Show more ▾ This medication helps to stop infection symptoms such as fever, cough, tiredness, and shortness of breath. A hydroxynaphthoquinone that has antimicrobial activity and is being used in antimalarial protocols. In 2024, this provider wrote 20 Medicare prescriptions for Atovaquone, about 82% of the volume of the typical New York prescriber of this medication (24.3). Medicare paid an average of $703.17 per fill, versus $483.25 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 28 30-Day Fills standardized to 30-day supplies 822 Days of Medication total across all patients in 2024 | |||
| Posaconazole | 18 | $1,483.64 | ▼ Less than typical |
About Posaconazole: Posaconazole is used to prevent certain fungal infections in patients who have severely weakened immune systems (such as patients who have had chemotherapy). Show more ▾ It belongs to a class of drugs known as azole antifungals. It works by stopping the growth of fungi. In 2024, this provider wrote 18 Medicare prescriptions for Posaconazole, about 72% of the volume of the typical New York prescriber of this medication (24.9). Medicare paid an average of $1,483.64 per fill, versus $1,242.17 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2024 | |||
| Folic Acid | 17 | $39.11 | ▼ Less than typical |
About Folic Acid: Folic acid is the man-made form of folate. Show more ▾ Folate is a B-vitamin naturally found in some foods. It is needed to form healthy cells, especially red blood cells. Folic acid supplements may come in different forms (such as L-methylfolate, levomefolate, methyltetrahydrofolate). They are used to treat or prevent low folate levels. Low folate levels can lead to certain types of anemia. Conditions that can cause low folate levels include poor diet, pregnancy, alcoholism, liver disease, certain stomach/intestinal problems, kidney dialysis, among others. Women of childbearing age should receive adequate amounts of folic acid either through their diet or supplements to prevent infant spinal cord birth defects. A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia. In 2024, this provider wrote 17 Medicare prescriptions for Folic Acid, about half the volume of the typical New York prescriber of this medication (30.9). Medicare paid an average of $39.11 per fill, versus $4.40 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 48.3 30-Day Fills standardized to 30-day supplies 1,450 Days of Medication total across all patients in 2024 | |||
| Levofloxacin | 17 | $12.63 | ▼ Less than typical |
About Levofloxacin: Levofloxacin is used to treat a variety of bacterial infections. Show more ▾ This medication belongs to a class of drugs known as quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. The L-isomer of Ofloxacin. In 2024, this provider wrote 17 Medicare prescriptions for Levofloxacin, about 65% of the volume of the typical New York prescriber of this medication (26.2). Medicare paid an average of $12.63 per fill, versus $5.47 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 371 Days of Medication total across all patients in 2024 | |||
| Metoprolol Succinate | 16 | $1.67▼ below NY avg | ▼ Less than typical |
About Metoprolol Succinate: This medication is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This lowers heart rate, blood pressure, and strain on the heart. A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS. In 2024, this provider wrote 16 Medicare prescriptions for Metoprolol Succinate, about 13% of the volume of the typical New York prescriber of this medication (125.8). Medicare paid an average of $1.67 per fill, versus $14.99 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 22 30-Day Fills standardized to 30-day supplies 660 Days of Medication total across all patients in 2024 | |||
| Febuxostat | 16 | $48.89▼ below NY avg | ▼ Less than typical |
About Febuxostat: Febuxostat is used to lower uric acid levels in people with gout. Show more ▾ Febuxostat works by reducing the amount of uric acid made by the body. An increased uric acid level can cause gout. Because of the risk of very serious heart-related problems and stroke with febuxostat (see also Warning section), febuxostat should be used only after treatment with a medication called allopurinol did not work to lower your uric acid level, caused serious side effects, or is not recommended by your doctor. Febuxostat should be used only if you have symptoms caused by a high blood uric acid level. A thiazole derivative and inhibitor of XANTHINE OXIDASE that is used for the treatment of HYPERURICEMIA in patients with chronic GOUT. In 2024, this provider wrote 16 Medicare prescriptions for Febuxostat, about 66% of the volume of the typical New York prescriber of this medication (24.4). Medicare paid an average of $48.89 per fill, versus $107.36 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 22 30-Day Fills standardized to 30-day supplies 660 Days of Medication total across all patients in 2024 | |||
| Doxycycline Hyclate | 16 | $7.89▼ below NY avg | ▼ Less than typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2024, this provider wrote 16 Medicare prescriptions for Doxycycline Hyclate, about half the volume of the typical New York prescriber of this medication (30.4). Medicare paid an average of $7.89 per fill, versus $11.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 16 30-Day Fills standardized to 30-day supplies 196 Days of Medication total across all patients in 2024 | |||
| Famotidine | 15 | $14.81 | ▼ Less than typical |
About Famotidine: Famotidine is used to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed. Show more ▾ This medication is also used to treat certain stomach and throat (esophagus) problems (such as erosive esophagitis, gastroesophageal reflux disease-GERD, Zollinger-Ellison syndrome). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as cough that doesn't go away, stomach pain, heartburn, and difficulty swallowing. Famotidine belongs to a class of drugs known as H2 blockers. This medication is also available without a prescription. It is used to prevent and treat heartburn and other symptoms caused by too much acid in the stomach (acid indigestion). If you are taking this medication for self-treatment, it is important to read the manufacturer's package instructions carefully so you know when to consult your doctor or pharmacist. A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. In 2024, this provider wrote 15 Medicare prescriptions for Famotidine, about a quarter of the volume of the typical New York prescriber of this medication (68.5). Medicare paid an average of $14.81 per fill, versus $13.04 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 37 30-Day Fills standardized to 30-day supplies 1,110 Days of Medication total across all patients in 2024 | |||
| Hydroxyurea | 14 | $30.42 | ▼ Less than typical |
About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾ Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. In 2024, this provider wrote 14 Medicare prescriptions for Hydroxyurea, about a third of the volume of the typical New York prescriber of this medication (35.9). Medicare paid an average of $30.42 per fill, versus $21.65 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 18 30-Day Fills standardized to 30-day supplies 516 Days of Medication total across all patients in 2024 | |||
| CresembaIsavuconazonium Sulfate | 14 | $6,055.90 | ≈ Typical |
About Cresemba: This medication is used to treat certain serious fungal infections. Show more ▾ This medication is known as an azole antifungal. It works by stopping the growth of fungi. In 2024, this provider wrote 14 Medicare prescriptions for Cresemba, about the same volume as the typical New York prescriber of this medication (14.7). Medicare paid an average of $6,055.90 per fill, versus $5,979.68 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14 30-Day Fills standardized to 30-day supplies 388 Days of Medication total across all patients in 2024 | |||
| Triamcinolone Acetonide | 12 | $15.59 | ▼ Less than typical |
About Triamcinolone Acetonide: This medication is used to treat a variety of skin conditions (such as eczema, dermatitis, allergies, rash). Show more ▾ Triamcinolone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a medium- to strong-potency corticosteroid. The potency depends on the strength and the form that you use. For details on the potency of your product, ask your pharmacist. An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions. In 2024, this provider wrote 12 Medicare prescriptions for Triamcinolone Acetonide, about a quarter of the volume of the typical New York prescriber of this medication (43.7). Medicare paid an average of $15.59 per fill, versus $15.21 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 250 Days of Medication total across all patients in 2024 | |||
| PaxlovidNirmatrelvir/Ritonavir | 11 | $0.00▼ below NY avg | ▼ Less than typical |
About Paxlovid: This combination of nirmatrelvir and ritonavir is used to treat coronavirus disease (COVID-19) in people who have mild to moderate symptoms and have a high risk for COVID-19 complications. Show more ▾ It helps people who have COVID-19 to stay out of the hospital. It is not for use by people who are hospitalized due to COVID-19. Nirmatrelvir is a SARS-CoV-2 main protease inhibitor. It works by preventing the growth of the virus that causes COVID-19. Ritonavir increases ("boosts") the levels of nirmatrelvir. This helps nirmatrelvir work better. This medication works by stopping the coronavirus from growing. It cannot be used to prevent COVID-19. In 2024, this provider wrote 11 Medicare prescriptions for Paxlovid, about half the volume of the typical New York prescriber of this medication (19.2). How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 11 30-Day Fills standardized to 30-day supplies 55 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for CHRISTINA BALDWIN N.P. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Adult Health prescribing approach at this New York, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NY prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
